What is Carbidopa-Levodopa?
Category: Prescription Drugs
Most popular types: Sinemet Carbidopa-Levodopa 25-100 Sinemet 25/100 Show all
Levodopa is a dopamine precursor used to treat the movement disorder symptoms of Parkinson's disease. Carbidopa is often included with levodopa-containing drugs in order to boost its efficacy by slowing down the metabolism of dopamine.
| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Parkinson's disease | 14871 | 2162 | |
| Multiple system atrophy | 304 | 64 | |
| Restless legs syndrome | 165 | 73 | |
| Stiffness/spasticity | 119 | 91 | |
| Dystonia | 94 | 50 | |
| Progressive supranuclear palsy | 90 | 15 |
- Major
- Moderate
- Slight
- None
- Can't tell
Side effects
Side effects as an overall problem
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 101 | |
| Moderate | 425 | |
| Mild | 700 | |
| None | 1078 |
Commonly reported side effects and conditions associated with Carbidopa-Levodopa
| Side effect | Patients | Percentage |
|---|---|---|
| Jerky movements | 166 | |
| Nausea | 154 | |
| Drowsiness | 48 | |
| Constipation | 35 | |
| Headaches | 28 | |
| Fatigue | 22 |
Why patients stopped taking Carbidopa-Levodopa
Multiple reasons could be selected
| Reason | Patients | Percentage |
|---|---|---|
| Doctor's advice | 146 | |
| Did not seem to work | 118 | |
| Side effects too severe | 102 | |
| Other | 84 | |
| Personal research | 31 | |
| Course of treatment ended | 19 | |
| Change in health plan coverage | 9 | |
| Expense | 5 |
Duration
Stopped taking Carbidopa-Levodopa
| Duration | Patients | Percentage |
|---|---|---|
| Less than 1 month | 50 | |
| 1 - 6 months | 86 | |
| 6 months - 1 year | 54 | |
| 1 - 2 years | 67 | |
| 2 - 5 years | 98 | |
| 5 - 10 years | 43 | |
| 10 years or more | 19 |
What people switch to and from
Patients started taking Carbidopa-Levodopa after stopping:
| Treatment | Patients | Percentage |
|---|---|---|
| Ropinirole (Requip) | 58 | |
| Pramipexole (Mirapex) | 48 | |
| Rasagiline (Azilect) | 29 | |
| Amantadine (Symmetrel) | 27 | |
| Carbidopa-Entacapone-Levodopa (Stalevo) | 21 |
Patients stopped taking Carbidopa-Levodopa and switched to:
| Treatment | Patients | Percentage |
|---|---|---|
| Carbidopa Levodopa ER (Rytary XR) | 92 | |
| Carbidopa-Entacapone-Levodopa (Stalevo) | 39 | |
| Ropinirole (Requip) | 20 | |
| Pramipexole (Mirapex) | 17 | |
| Amantadine (Symmetrel) | 14 |
Last updated: